News and reflections from the world of AI

    Using AI-based image analysis to predict ovarian tumor outcome

    High-grade extrauterine serous carcinoma (HGSC) is an aggressive tumor with high rates of recurrence, mainly found in ovaries. These tumors have ...
    Written by Aiforia

    Introduction to tCECs: a novel method for cancer diagnostics

    Cancer Diagnostics Expedited by the COVID-19 pandemic and the disruption it caused to healthcare systems, cancer rates are rising worldwide. Yet, ...
    Written by Aiforia

    Interview with Emilian Gheorghe on using AI models for breast cancer grading

    While breast cancer is a leading cause of cancer death in women worldwide, current approaches for diagnosis and therapy are in need of an upgrade. ...
    Written by Aiforia
    March 16, 2021

    Validation of PD-L1 AI model launches in six labs across the Netherlands

    Introduction  Programmed death-ligand 1 (PDL1) is a protein that, when attached to T cells, prevent the immune system from killing cancer cells. Hence, PDL1 is used as a biomarker for tumor immune escape, a sign of increasing cancer progression. PDL1 percentage is also a significant predictor for immunotherapy efficacy, whereby immune checkpoint inhibitors bind to PDL1 and block its ability to ...
    Written by Aiforia
    March 11, 2021

    Interview with Dr. Rish Pai on using AI to study colorectal cancer

    Introduction Colorectal cancer is the third most common cancer in the United States and pathologists are becoming increasingly valuable in the management of these patients. Analysis of histological features of the tumors is the main source of data for diagnosis, but there are many components to this. Routine pathologic assessment does not capture a quantitative view of the extensive variability ...
    Written by Aiforia
    January 11, 2021

    The impact of digital pathology on immuno-oncology

    Immuno-oncology (IO) relies on harnessing our own immune systems in order to develop personalized therapies and medications for cancer. For this, a deep understanding of the immune system as well as its role in the regulation of the tumor microenvironment (TME) is pivotal. 
    Written by Aiforia
    1 2